Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5001
CALL
Cooper Companies
COO
$14.6B
| $202K | ﹤0.01% |
+2,400
| New | +$180K |
|
5002
PUT
Element Solutions
ESI
$9.34B
| $202K | ﹤0.01% |
19,500
-17,900
| -48% | -$188K |
|
5003
Kodiak Sciences
KOD
$2.73B
| $202K | ﹤0.01% |
17,283
+14,600
| +544% | +$130K |
|
5004
Limoneira
LMNR
$249M
| $202K | ﹤0.01% |
10,135
+5,831
| +135% | +$124K |
|
5005
SIGA Technologies
SIGA
$226M
| $202K | ﹤0.01% |
35,518
-16,813
| -32% | -$93.1K |
|
|
SOHU
5006
Sohu.com
SOHU
$359M
| $202K | ﹤0.01% |
14,473
-62,585
| -81% | -$989K |
|
5007
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$233M
| $202K | ﹤0.01% |
3
| – | – |
|
5008
CALL
Marriott Vacations Worldwide
VAC
$3.49B
| $202K | ﹤0.01% |
2,096
+700
| +50% | +$69K |
|
|
CDMO
5009
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $202K | ﹤0.01% |
36,135
+21,813
| +152% | +$89.9K |
|
5010
Primis Financial Corp
FRST
$409M
| $201K | ﹤0.01% |
13,114
+7,132
| +119% | +$105K |
|
|
KNDI
5011
PUT
Kandi Technologies Group
KNDI
$69.8M
| $201K | ﹤0.01% |
40,800
-22,100
| -35% | -$112K |
|
|
SRNE
5012
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $201K | ﹤0.01% |
75,416
+42,985
| +133% | +$155K |
|
|
FPRX
5013
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $201K | ﹤0.01% |
33,453
+11,526
| +53% | +$110K |
|
5014
CALL
FirstCash
FCFS
$9.02B
| $200K | ﹤0.01% |
2,000
| – | – |
|
|
RJET
5015
Republic Airways Holdings
RJET
$1.01B
| $200K | ﹤0.01% |
1,460
-367
| -20% | -$50.6K |
|
|
MRSH
5016
PUT
Marsh
MRSH
$91.4B
| $200K | ﹤0.01% |
2,000
+1,400
| +233% | +$134K |
|
5017
PUT
NewMarket
NEU
$8.11B
| $200K | ﹤0.01% |
+500
| New | +$207K |
|
|
BELFB
5018
Bel Fuse Inc Class B
BELFB
$4.18B
| $199K | ﹤0.01% |
11,548
+383
| +3% | +$8.09K |
|
|
EBTC
5019
DELISTED
Enterprise Bancorp
EBTC
| $199K | ﹤0.01% |
6,268
+3,208
| +105% | +$95.7K |
|
|
EEX
5020
DELISTED
Emerald Holding
EEX
| $199K | ﹤0.01% |
17,775
+9,319
| +110% | +$116K |
|
5021
Home Bancorp
HBCP
$567M
| $199K | ﹤0.01% |
5,178
+2,107
| +69% | +$76.2K |
|
5022
PUT
Royal Bank of Canada
RY
$294B
| $199K | ﹤0.01% |
2,500
-300
| -11% | -$23.4K |
|
5023
Direxion Daily Small Cap Bear 3x ETF
TZA
$213M
| $199K | ﹤0.01% |
55
+19
| +53% | +$72.7K |
|
|
KIN
5024
DELISTED
Kindred Biosciences, Inc.
KIN
| $199K | ﹤0.01% |
23,881
+11,426
| +92% | +$98.6K |
|
5025
American Superconductor
AMSC
$1.6B
| $198K | ﹤0.01% |
21,347
-80,831
| -79% | -$860K |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.